To correlate genetic markers to mechanisms of disease and gain further inside into disease aetiology, we perform a multi-level –omics approach using tissues and peripheral fluid biomarkers. We further investigate targets and markers for drug response with flowcytometry, immunhistochemistry, ELISA array platforms and western blot and gene expression studies (RNA seq, microarray, quantitative RT PCR). The biomarker data is combined with genetic and imaging data to find biomarkers for prediction, improved diagnostics and treatment response in affective disorders.​

GeN Ltd
Office 7 35-37 Ludgate Hill
London, England


diseño alauna